Annual Report

Overview

The report presents Novo Nordisk's 2025 performance across its global pharmaceutical operations, with net sales of DKK 309,064 million and year-end headcount of 69,505 after a company-wide transformation. Sustainability disclosures cover ESRS-based double materiality, climate, workforce, resource use and other material topics. Market-based total GHG emissions increased to 2,690 1,000 tCO2e, while the company maintained targets for a 33% Scope 3 reduction by 2033 and net zero by 2045.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2025
Period: 1 January 2025 – 31 December 2025
Language: English
Pages
File size
Restatement: Disclosed

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level
SBTi status
CDP score

Materiality

Assessment
Basis

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services